Insulin

BOSTON — Tumor samples from Black women diagnosed with triple-negative breast cancer expressed higher levels of insulin signaling than samples from white women, suggesting hyperinsulinemia may play a role in disease outcomes, data show.

An FDA committee declined to recommend approval for a once-weekly insulin to improve glycemic control for adults with type 1 diabetes.

Women with obesity who undergo bariatric surgery and have higher levels of insulin have a lower risk for breast cancer than women who do not undergo surgery, according to findings published in JAMA Surgery.

Eating a low-fat vegan diet induced a greater improvement in insulin sensitivity and a larger reduction in total daily insulin dose than a portion-controlled diet for adults with type 1 diabetes, according to study findings.

Annual expenditures for diabetes medications more than tripled in the U.S. from 2011 to 2020, and the increase played a role in an overall rise in money spent on prescription drugs, according to study findings.

Adults who received tirzepatide experienced greater weight loss than those who received placebo, regardless of each patient’s length of history of obesity, according to a post-hoc analysis of four SURMOUNT trials.

Insulin out-of-pocket caps were associated with reduced insulin costs but not increased insulin use, according to a study published in the Annals of Internal Medicine.

Prices for most diabetes medications exceed their manufacturing costs, and the addition of generic or biosimilar medications could help to lower prices, according to study findings published in JAMA Network Open.

A once-weekly basal insulin conferred similar changes in HbA1c and time in range as once-daily insulin glargine among adults with type 1 and type 2 diabetes in three phase 2 trials, according to a speaker.

The FDA granted 510(k) clearance for an automated insulin delivery system that can measure the volume and flow of insulin within every micro-dose, according to an industry press release.